Page last updated: 2024-09-05

organophosphonates and Atherogenesis

organophosphonates has been researched along with Atherogenesis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eller, P; Patsch, JR; Ritsch, A; Tancevski, I1
Bacchetti, P; Biggs, ML; Currier, JS; Delaney, JA; Grunfeld, C; Kronmal, RA; O'leary, D; Polak, JF; Scherzer, R; Shliplak, MG; Tien, PC; Wanke, C1
Alonso-Villaverde, C; Aragonès, G; Beltrán-Debón, R; Camps, J; Fernández-Sender, L; Joven, J; Pardo-Reche, P; Rodríguez-Gallego, E; Rull, A1

Reviews

1 review(s) available for organophosphonates and Atherogenesis

ArticleYear
The resurgence of thyromimetics as lipid-modifying agents.
    Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:9

    Topics: Acetates; Anilides; Animals; Anticholesteremic Agents; Arteriosclerosis; Atherosclerosis; Biological Transport; Biomimetics; Cholesterol, LDL; Clinical Trials as Topic; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Malonates; Molecular Structure; Organophosphonates; Phenols; Phenyl Ethers; Phenylacetates; Propionates; Pyridazines; Receptors, LDL; Thyroid Gland; Thyroid Hormones

2009

Other Studies

2 other study(ies) available for organophosphonates and Atherogenesis

ArticleYear
Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness.
    AIDS (London, England), 2010, Sep-10, Volume: 24, Issue:14

    Topics: Adenine; Antiretroviral Therapy, Highly Active; Atherosclerosis; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Risk Factors; Tenofovir; Tunica Intima; Tunica Media

2010
The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients.
    Mediators of inflammation, 2012, Volume: 2012

    Topics: Adenine; Atherosclerosis; Chemokine CCL2; HIV Infections; Interleukin-6; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir

2012